The
power conversion efficiency (PCE) of perovskite solar cells
has been showing rapid improvement in the last decade. However, still,
there is an unarguable performance deficit compared with the Schockley–Queisser
(SQ) limit. One of the major causes for such performance discrepancy
is surface and grain boundary defects. They are a source of nonradiative
recombination in the devices that not only causes performance loss
but also instability of the solar cells. In this study, we employed
a direct postsurface passivation strategy at mild temperatures to
modify perovskite layer defects using tetraoctylammonium chloride
(TOAC). The passivated perovskite layers have demonstrated extraordinary
improvement in photoluminescence and charge carrier lifetimes compared
to their control counterparts in both Cs0.05(FAPbI3)0.83(MAPbBr3)0.17 and MAPbI3-type perovskite layers. The investigation on electron-only
and hole-only devices after TOAC treatment revealed suppressed electron
and hole trap density of states. The electrochemical study demonstrated
that TOAC treatment improved the charge recombination resistance of
the perovskite layers and reduced the charge accumulation on the surface
of perovskite films. As a result, perovskite solar cells prepared
by TOAC treatment showed a champion PCE of 21.24% for the Cs0.05(FAPbI3)0.83(MAPbBr3)0.17-based device compared to 19.58% without passivation. Likewise, the
PCE of MAPbI3 improved from 18.09 to 19.27% with TOAC treatment.
The long-term stability of TOAC-passivated perovskite Cs0.05(FAPbI3)0.83(MAPbBr3)0.17 devices has retained over 97% of its initial performance after 720
h in air.
The power conversion efficiency (PCE) of perovskite solar
cells
(PSCs) has increased and levels with silicon solar cells; however,
their commercialization has not yet been realized because of their
poor long-term stability. One of the primary causes of the instability
of PSC devices is the large concentration of defects in the polycrystalline
perovskite film. Such defects limit the device performance besides
triggering hysteresis and device instability. In this study, tetradodecylammonium
bromide (TDDAB) was used as a postsurface modifier to suppress the
density of defects from the mixed perovskite film (CsFAMA). X-ray
photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy
(FTIR) analyses validated that TDDAB binds to the mixed perovskite
through hydrogen bonding. The X-ray diffraction (XRD) and two-dimensional
grazing incidence wide-angle X-ray scattering (2D GIWAXS) study uncovered
that the TDDAB modification formed a capping layer of (TDDA)2PbI1.66Br2.34 on the surface of the three-dimensional
(3D) perovskite. The single charge transport device prepared from
the TDDAB-modified perovskite film revealed that both the electron
and hole defects were considerably repressed due to the modification.
Consequently, the modified device displayed a champion PCE of 21.33%.
The TDDAB surface treatment not only enhances the PCE but the bulky
cation of the TDDAB also forms a hydrophobic capping surface (water
contact angle of 93.39°) and safeguards the underlayer perovskite
from moisture. As a result, the modified PSC has exhibited almost
no performance loss after 30 days in air (RH ≈ 40%).
A wide variety of two-dimensional (2D) metal dichalcogenide compounds have recently attracted much research interest due to their very high photoresponsivities (R) making them excellent candidates for optoelectronic applications. High...
Among the layered two dimensional semiconductors, molybdenum disulfide (MoS2) is considered to be an excellent candidate for applications in optoelectronics and integrated circuits due to the layer-dependent tunable bandgap in...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.